from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2359/zur

LFCtreatmentdescriptionclass of inhibitor

-0.047

Amikacinug/mL Amikacintranslation

-0.297

Cap5-10ug/mL Capreomycintranslation

-0.708

Rox10-50 ug/mL Roxithromycintranslation

-0.495

SM2-5 ug/mL Streptomycintranslation

-0.983

Tet5-10 ug/mL Tetracyclinetranslation

0.846

Rif0.2-5ug/mL Rifampicintranscription

0.378

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.210

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.201

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.627

CPZ10-50 ug/mL Chlorpromazinerespiration

1.484

Clofazimine10-13 ug/mL Clofaziminerespiration

0.449

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.681

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.098

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.963

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.659

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.081

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.133

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.774

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.901

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.459

KCN5-20 ug/mL Potassium cyaniderespiration

0.153

NaN30.2-2 mM Sodium aziderespiration

-0.512

Nigericin50 uM Nigericinrespiration

0.928

TRC10-150 ug/mL Triclosanrespiration

1.168

TRZ10-25 ug/mL Thioridazinerespiration

-0.735

Valinomycin0.5-10 uM Valinomycinrespiration

0.868

ZnSO42 mM ZnSO4respiration

0.404

menadione6-10 ug/mL Menadionerespiration

0.936

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.776

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.070

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.844

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.343

NRP_1Non-replicating persistence stage 1dosRassociated

-0.719

Amp0.2mg/mL AmpicillincellWall

-0.832

Cephalexin20-100 ug/mL CephalexincellWall

-0.441

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.012

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.178

EMB10-20 ug/mL EthambutolcellWall

-0.138

Eta12-40 ug/mL EthionamidecellWall

-0.516

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.028

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.232

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.638

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.261

BZA0.12 mg/mL BenzamidearomaticAmides

-0.395

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.796

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.610

H2O24 mM hydrogen peroxideDNAdamaging

-0.776

Levo10 ug/mL LevofloxacinDNAdamaging

-1.072

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.724

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.556

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.039

UVUV-irradiationDNAdamaging

1.277

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.449

Antimycin12.5-50 ug/mL Antimycin A?

-0.568

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.479

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.330

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.441

PA8240.2-2 ug/mL PA-824?

1.803

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.045

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.722

Verapamil50 uM Verapamil?

-1.033

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.509

methoxatin10-20 ug/mL Methoxatin?